| Structure | Chemical Name | CAS | MF |
|
Ethanone, 1-pyrazinyl-, oxime (9CI)
|
141190-61-6
|
C6H7N3O
|
|
ALFA-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-BENZENACETIC ACID METHYL ESTER
|
141190-94-5
|
C14H19NO4
|
|
1H-pyrazole-3,5-diaMine hydrochloride
|
141193-12-6
|
C3H7ClN4
|
|
6-Chloro-N-methyl-N-(phenylmethyl)- 3-Pyridazinamine
|
141193-20-6
|
C12H12ClN3
|
|
1,4,5,8-naphthalene tetracarboxylic acid 4,5-anhydride
|
141193-56-8
|
C14H7NaO8
|
|
N-Me-Ser-OH·HCl
|
141193-65-9
|
C4H10ClNO3
|
|
Ethanone, 2-bromo-1-[(2R)-tetrahydro-2-furanyl]- (9CI)
|
141194-58-3
|
C6H9BrO2
|
|
Ethanone, 2-bromo-1-[(2S)-tetrahydro-2-furanyl]- (9CI)
|
141194-61-8
|
C6H9BrO2
|
|
Ethanone, 2-chloro-1-[tetrahydro-5-(methoxymethyl)-2-furanyl]-, (2S-cis)- (9CI)
|
141194-64-1
|
C8H13ClO3
|
|
Cefovecin sodium
|
141195-77-9
|
C17H18N5NaO6S2
|
|
2-Furancarboxylicacid,tetrahydro-5-(methoxymethyl)-,(2R-trans)-(9CI)
|
141196-06-7
|
C7H12O4
|
|
2-Furancarboxylicacid,tetrahydro-5-(methoxymethyl)-(9CI)
|
141196-07-8
|
C7H12O4
|
|
(S)-2-(Methoxymethyl)morpholine HCl
|
141196-38-5
|
C6H14ClNO2
|
|
(R)-2-(Methoxymethyl)morpholine HCl
|
141196-39-6
|
C6H13NO2.HCl
|
|
DL-2-(2-Chlorophenyl)glycine
|
141196-64-7
|
C8H8ClNO2
|
|
7-oxostaurosporine
|
141196-69-2
|
C28H24N4O4
|
|
troxacitabine
|
141196-85-2
|
C8H11N3O4
|
|
1H-Pyrrolizin-1-amine,hexahydro-,(1R,7aR)-rel-(9CI)
|
141197-03-7
|
C7H14N2
|
|
(+)-Ipratropine
|
141197-26-4
|
C20H30NO3+
|
|
(-)-Ipratropine
|
141197-27-5
|
C20H30NO3+
|
|
7-(2-(2-aminothiazol-4-yl)- 2-(1-carboxyl-1-methylethoxyimino)acetamido)-3-(3-(3,4-dihydroxybenzoyloxy)-1-propen-1-yl)-3-cephem-4-carboxylic acid
|
141197-54-8
|
C26H25N5O11S2
|
|
darglitazone
|
141200-24-0
|
C23H20N2O4S
|
|
microcolin A
|
141205-31-4
|
C39H65N5O9
|
|
microcolin B
|
141205-32-5
|
C39H65N5O8
|
|
perilloside A
|
141206-20-4
|
C16H26O6
|
|
N-Butyl-1-deoxygalactonojirimycin
|
141206-42-0
|
C10H21NO4
|
|
5-Isoxazoleethanol,-alpha--methyl-,acetate(ester)(9CI)
|
141207-11-6
|
C8H11NO3
|
|
Cyclobutanecarboxylic acid, 2,3-bis(hydroxymethyl)-, [1S-(1alpha,2alpha,3beta)]- (9CI)
|
141208-49-3
|
C7H12O4
|
|
3-DIMETHYLAMINOMETHYLENE-1,3-DIHYDRO-INDOL-2-ONE
|
141210-63-1
|
C11H12N2O
|
|
Methanamine, 1-(2-ethoxy-3H-indol-3-ylidene)-N,N-dimethyl-, (E)- (9CI)
|
141210-78-8
|
C13H16N2O
|
|
Methanamine, 1-(2-ethoxy-3H-indol-3-ylidene)-N,N-dimethyl-, (Z)- (9CI)
|
141210-80-2
|
C13H16N2O
|
|
1H-Indole-3-carboxaldehyde,2-ethoxy-1-ethyl-(9CI)
|
141210-88-0
|
C13H15NO2
|
|
1-(2-chlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazole
|
141211-37-2
|
C16H15ClN2
|
|
PROPOFOL RELATED COMPOUND C (50 MG) (2,6-DIISOPROPYLPHENYL ISOPROPYLETHER)
|
141214-18-8
|
C15H24O
|
|
4,7-dibromobenzo[c][1,2,5]thiadiazole-5,6-diamine
|
141215-32-9
|
C6H4Br2N4S
|
|
ANTHRANILYL-HIV PROTEASE SUBSTRATE IV
|
141223-69-0
|
C56H88N16O14
|
|
BENZYLOXYCARBONYL-L-VALYL-L-LYSYL-L-METHIONINE 4-METHYLCOUMARYL-7-AMIDE HYDROCHLORIDE
|
141223-71-4
|
C34H45N5O7S
|
|
DANTNP
|
141227-99-8
|
C8H5N13O6
|
|
substance P, N-spermine-Gln(5)-
|
141231-59-6
|
C73H121N21O13S
|
|
4-Amino-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
|
141232-24-8
|
C13H15N5O4
|
|
2-Cyclobutene-1-carboxylic acid, 1-formyl-, methyl ester (9CI)
|
141232-84-0
|
C7H8O3
|
|
2H-Pyran-5-carboxylicacid,methylester(9CI)
|
141232-86-2
|
C7H8O3
|
|
2-Cyclobutene-1-carboxylicacid,1-(hydroxymethyl)-,methylester(9CI)
|
141232-88-4
|
C7H10O3
|
|
2-Methylquinoline-5-carbaldehyde
|
141234-07-3
|
C11H9NO
|
|
(5-METHOXY-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL)-ACETIC ACID
|
141234-08-4
|
C9H6N2O
|
|
HIV-1 REV PROTEIN (34-50)
|
141237-50-5
|
C97H173N51O24
|
|
Benzoic acid, 3-amino-4-(methylthio)-, methyl ester (9CI)
|
141238-13-3
|
C9H11NO2S
|
|
Benzoic acid, 3-amino-4-ethoxy-, ethyl ester (9CI)
|
141238-15-5
|
C11H15NO3
|
|
3-chloro-5-nitropicolinic acid
|
141238-23-5
|
C6H3ClN2O4
|
|
6-(2,4-dichlorophenyl)-2,3,4-trihydroxyhexanesulfonic acid
|
141240-46-2
|
C12H17Cl2NaO6S
|
|
N-phenyl-1H-benzo[d][1,2,3]triazol-1-carboxiMidaMide
|
141240-68-8
|
C13H11N5
|
|
phenyl 1H-benzo[d][1,2,3]triazol-1-carbiMidothioate
|
141240-69-9
|
C13H10N4S
|
|
(2,4-DIBROMO-PHENOXY)-ACETIC ACID HYDRAZIDE
|
141244-86-2
|
C8H8Br2N2O2
|
|
2(3H)-Benzofuranone, 3-(hydroxymethylene)-, (E)- (9CI)
|
141250-32-0
|
C9H6O3
|
|
Sodium dilaureth citrate
|
141250-39-7
|
|
|
|
SODIUM LAURETH-7 TARTRATE
|
141250-42-2
|
|
|
2,7-Naphthalenedisulfonic acid, 4-amino-3,6-bis5-4-chloro-6-(2-methyl-4-sulfophenyl)amino-1,3,5-triazin-2-ylamino-2-sulfophenylazo-5-hydroxy-, sodium salt
|
141250-43-3
|
C42H34Cl2N15NaO19S6
|
|
|
androsol acetate
|
141255-16-5
|
|
|
|
GT1aalpha ganglioside
|
141255-28-9
|
|
|
|
Reactive blue 214
|
141255-32-5
|
|
|
|
Reactive yellow 165
|
141255-35-8
|
|
|
QS 21
|
141256-04-4
|
C92H148O46
|
|
|
MATRILYSIN
|
141256-52-2
|
|
|
3-O-((xylopyranosyl-1-3-xylopyranosyl-1-4-rhamnopyranosyl-1-2)-(rhamnopyranosyl-1-4)-glucopyranosyl)-3,16-trihydroxyolean-12-en-28-oic acid
|
141258-70-0
|
C58H94O26
|
|
D-Fructose-2,5-13C2
|
141258-84-6
|
C6H12O6
|
|
cyclo-RGDPhg
|
141261-62-3
|
C20H27N7O6
|
|
BOC-TYR-PRO-GLY-PHE-LEU-THR-OH
|
141261-96-3
|
C40H56N6O11
|
|
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside
|
141263-01-6
|
C29H32O5S
|
|
Ethyl 2,3,6-tri-O-benzyl-1-thio-b-D-glucopyranoside
|
141263-02-7
|
C29H34O5S
|
|
6-(2,4-dichlorophenyl)-erythro-2,4-dihydroxyhexylphosphonic acid
|
141263-54-9
|
C12H17Cl2O5P
|
|
6-(2,4-dichlorophenyl)-2,4-dihydroxyhexane-1-sulfonic acid
|
141263-69-6
|
|
|
Benzamide, N-formyl-N-methyl- (9CI)
|
141264-25-7
|
C9H9NO2
|
|
5-(6-Chloro-2,4-dioxo-1,3,4,10-tetrahydro-2H-9-oxa-1,3-diaza-anthracen-10-yl)-pyrimidine-2,4,6-trione
|
141266-44-6
|
C15H9ClN4O6
|
|
2,6,7-trideoxy-7-C-(2,4-dichlorophenyl)heptonic acid
|
141267-47-2
|
C13H15Cl2NaO5
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,[1S-(1alpha,2beta,3alpha,6alpha)]-(9CI)
|
141269-14-9
|
C6H11NO3
|
|
2-Furancarboxylic acid, 5-(chloroacetyl)tetrahydro-, methyl ester, (2S-cis)- (9CI)
|
141269-24-1
|
C8H11ClO4
|
|
terazosin hydrochloride
|
141269-44-5
|
C19H26ClN5O4
|
|
terazosin hydrochloride
|
141269-45-6
|
C19H26ClN5O4
|
|
3,4-dichloro-N-methyl-N-(3-methylene-2-oxo-8-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-7-yl)benzeneacetamide
|
141269-53-6
|
|
|
(S)-4-[2-HYDROXY-3-PHENOXYPROPYLAMINOETHOXY]PHENOXYACETIC ACID HYDROCHLORIDE
|
141269-99-0
|
C19H23NO6
|
|
1,3-Dioxane,4,6-dimethyl-2-(1-methylethyl)-,[4S-(2alpha,4alpha,6bta)]-(9CI)
|
141271-05-8
|
C9H18O2
|
|
(1S,4R)-4-[(2,5-DiaMino-6-chloro-4-pyriMidinyl)aMino]-2-cyclopentene-1-Methanol
|
141271-11-6
|
C10H13ClN4O
|
|
Abacavir
|
141271-12-7
|
C10H14ClN5O
|
|
Cyclobutanecarboxylic acid, 2,3-bis(hydroxymethyl)-, [1R-(1alpha,2beta,3alpha)]- (9CI)
|
141271-21-8
|
C7H12O4
|
|
HP 736
|
141271-42-3
|
C17H21BrN2O5
|
|
bruceoside C
|
141271-79-6
|
C32H42O16
|
|
xestobergsterol B
|
141272-44-8
|
C27H44O7
|
|
xestobergsterol A
|
141272-45-9
|
C27H44O5
|
|
Hexanedioic acid, polymer with 2-(2-aminoethyl)aminoethanol, 1,3-bis(1-isocyanato-1-methylethyl)benzene, 2,2-dimethyl-1,3-propanediol, 1,6-hexanediol and 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid
|
141274-63-7
|
C40H74N4O15
|
|
3-METHYL-4-NITROBENZYL BROMIDE 97
|
141281-38-1
|
C8H8BrNO2
|
|
Pheromonotropin
|
141281-40-5
|
C101H155N25O30
|
|
1,2-Benzenediol, 3-[(phenylimino)methyl]-
|
141281-43-8
|
C13H11NO2
|
|
2-Naphthalenemethanol,3-amino-(9CI)
|
141281-58-5
|
C11H11NO
|
|
H-ALA-ASN-PRO-ASP-CYS-LYS-THR-ILE-LEU-LYS-ALA-LEU-GLY-PRO-ALA-ALA-THR-OH
|
141281-67-6
|
C73H126N20O23S
|
|
ramatroban
|
141281-95-0
|
C21H21FN2O4S
|
|
Tr-PEG6
|
141282-24-8
|
C29H36O6
|
|
H2N-PEG5-CH2COOH
|
141282-35-1
|
C12H25NO7
|
|
8-Nitro-2-tetrazol-5-yl-4-oxo-4H-1-benzopyran
|
141283-42-3
|
C10H5N5O4
|
|
ON 579
|
141286-14-8
|
C16H14ClF2NO5S2
|
|
2,6-DIFLUORO-4-[2-(PHENYLSULFONYLAMINO)E
|
141286-78-4
|
C16H16F2N2O4S2
|